To arrange an interview with a spokesperson for the TMIST (EA1151) breast cancer screening trial, please send an email or call 215.789.3631.
Amy Curtis, MD (Spartanburg Medical Center): Women are intrigued by the many questions asked in TMIST. Conversation with The Cancer Letter More Here
“Why I choose to play a dual role in TMIST” by Worta McCaskill-Stevens, Division of Cancer Prevention, National Cancer Institute, in The Cancer Letter More Here
“Are we further reducing breast cancer mortality the more intensively we screen?” Conversation with The Cancer Letter and TMIST study chair Etta Pisano, MD More Here
Landmark TMIST Breast Cancer Screening Trial to Inform Screening Policy. A conversation with study chair Etta D. Pisano, MD for the February 2019 E-Newsletter More Here